Rapid bloodstream infection (BSI) detection with InfectID™-BSI, the sepsis qPCR kit. Identifies major sepsis pathogens directly from blood samples. Fast, accurate, and easy to use.
We are looking for evaluation partners in Denmark, interested in testing this product
Price:
Send Request
InfectID™-BSI, the Sepsis qPCR Kit
Key Benefits for Clinicians and Healthcare providers.
Addressing the Limitations of Current Methods
- Sepsis qPCR Kit
- Detects 26 common sepsis-related bacterial and fungal pathogens
- Requires only 0.4 mL of whole blood
- Results within 4 hours
- CE-marked for IVD use
Enables Early Targeted Therapy
InfectID™-BSI delivers pathogen-specific information faster than blood culture, allowing clinicians to start more targeted treatments earlier.
Supports Antimicrobial Stewardship
By enabling more precise, early treatment, InfectID™-BSI reduces reliance on broad-spectrum antibiotics, helping to minimize AMR.
Enhanced Pathogen Detection
Standard of care often cannot culture fastidious pathogens or those that have been suppressed by prior antimicrobial therapy. InfectID™-BSI addresses these limitations by effectively identifying such pathogens, thereby closing critical gaps in diagnostic accuracy.
Broad Clinical Application
Designed for a wide range of clinical environments, InfectID™-BSI is ideal for use in intensive care units, emergency departments, and infectious disease clinics. Its ability to directly test whole blood with minimal sample size makes it especially suitable for neonatal and pediatric cases, as well as other patients where blood volume is difficult to provide.
Streamlined Workflow Integration
InfectID™-BSI’s rapid approach integrates seamlessly into existing laboratory workflows. Its compatibility with the QIAGEN® Rotor-Gene® Q platform, or Magnetic Induction Cycler (MIC) and user-friendly software ensures that results are consistent, repeatable, and easily interpreted, providing actionable insights in time-sensitive situations.
Developed, manufactured and supplied by Microbio
